|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Cytarabine. Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (649)
Cases resulting in a serious event (634)
Cases resulting in death (233)
Cases resulting in life threatening events (95)
Cases resulting in hospitalization (298)
Cases resulting in disability (43)
Cases resulting in other serious reactions (238)
Below is a sample of reports where side effects / adverse reactions may be related to Cytarabine. For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in 72 year old male receiving Cytarabine
Reported by a physician from United States on 2007-10-31
Patient: 72 year old male
Adverse reactions / side effects: Febrile Neutropenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Cytarabine
Dosage: 500 mg/m2, unk
Indication: Chronic Lymphocytic Leukaemia
Fludarabine Phosphate
Dosage: 30 mg/m2, unk
Indication: Chronic Lymphocytic Leukaemia
Oxaliplatin
Dosage: 30 mg/m2, unk
Indication: Chronic Lymphocytic Leukaemia
Start date: 2007-07-12
Pegfilgrastim
Dosage: 6 mg, unk
Indication: Chronic Lymphocytic Leukaemia
Rituximab
Dosage: 375 mg/m2, unk
Indication: Chronic Lymphocytic Leukaemia
Other drugs received by patient: Bactrim; Fluconazole; Lescol; Insulin; Levaquin; Pioglitazone; Compazine; Darvon; Quinapril HCL; Valtrex
Adverse event in 57 year old male receiving Cytarabine
Reported by a consumer/non-health professional from France on 2007-10-31
Patient: 57 year old male
Adverse reactions / side effects: Hyperthermia, Lung Neoplasm, Pancytopenia, Cholestasis, Cardiac Disorder, Liver Function Test Abnormal, Bone Marrow Failure, Hepatosplenomegaly, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Alkeran
Dosage: 280mg single dose
Start date: 2007-02-21
End date: 2007-02-21
Bicnu
Dosage: 600mg single dose
Start date: 2007-02-16
End date: 2007-02-16
Cytarabine
Dosage: 400mg twice per day
Start date: 2007-02-17
End date: 2007-02-20
Etoposide
Dosage: 400mg per day
Start date: 2007-02-17
End date: 2007-02-20
Kepivance
Dosage: 8mg per day
Start date: 2007-02-12
End date: 2007-02-25
Mabthera
Dosage: 500mg cumulative dose
Start date: 2007-02-08
End date: 2007-02-21
Zevalin
Dosage: 890mbq single dose
Start date: 2007-02-08
End date: 2007-02-08
Other drugs received by patient: Heparin; Zofran; Emend; Tazocilline; Fortum; Ciflox; Flagyl; Vancomycin; Caspofungin; Voriconazole; Ambisome; Zelitrex; Zovirax; Bactrim; Amiklin; Autograft OF Peripheral Blood Stem Cells; Granocyte; Tienam
Adverse event in 52 year old male receiving Cytarabine
Reported by a individual with unspecified qualification from Israel on 2007-10-31
Patient: 52 year old male
Adverse reactions / side effects: Drug Toxicity, Leukaemia, Bone Marrow Transplant, Hepatotoxicity, NO Therapeutic Response, Chronic Graft Versus Host Disease, Jaundice Cholestatic
Suspect drug(s):
Asparaginase(asparaginase) (Asparaginase)
Indication: B Precursor Type Acute Leukaemia
Cytarabine
Indication: B Precursor Type Acute Leukaemia
Daunorubicin HCL
Indication: B Precursor Type Acute Leukaemia
Dexamethasone
Indication: B Precursor Type Acute Leukaemia
Mercaptopurine
Indication: B Precursor Type Acute Leukaemia
Methotrexate
Dosage: intrathecal
Indication: B Precursor Type Acute Leukaemia
Methotrexate
Dosage: intrathecal
Indication: B Precursor Type Acute Leukaemia
Vincristine
Indication: B Precursor Type Acute Leukaemia
Other drugs received by patient: Cyclophosphamide; Cyclophosphamide; Lamivudine
Adverse event in female receiving Cytarabine
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female, weighing 96.5 kg (212.3 pounds)
Adverse reactions / side effects: Small Intestinal Obstruction
Adverse event resulted in: hospitalization
Suspect drug(s):
Cytarabine
Dosage: 1400 mg
Daunorubicin HCL
Dosage: 180 mg
Leukine
Dosage: 5500 mg
Adverse event in male receiving Cytarabine
Reported by a physician from United Kingdom on 2007-10-30
Patient: male
Adverse reactions / side effects: Acute Myeloid Leukaemia, Skin Hyperpigmentation, Disease Progression
Adverse event resulted in: death
Suspect drug(s):
Cytarabine
Dosage: unknown
Start date: 2007-06-04
Daunorubicin HCL
Dosage: unknown
Start date: 2007-06-04
Gemtuzumab Ozogamicin
Dosage: unknown
Start date: 2007-06-04
Adverse event in 28 year old female receiving Cytarabine
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: 28 year old female
Adverse reactions / side effects: Grand MAL Convulsion, Bone Marrow Failure, Leukoencephalopathy, Respiratory Distress, Convulsion, Cough, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Cytarabine
Indication: Burkitt's Lymphoma
Start date: 2007-08-28
End date: 2007-08-28
Endoxan
Indication: Burkitt's Lymphoma
Start date: 2007-08-23
End date: 2007-08-23
Methotrexate
Indication: Burkitt's Lymphoma
Start date: 2007-08-28
End date: 2007-08-28
Vincristine Sulfate
Indication: Burkitt's Lymphoma
Start date: 2007-08-23
End date: 2007-08-23
Other drugs received by patient: Rituxan; Doxorubicin HCL; Combivir; Sustiva; Inipomp; Cortancyl; Prednisone
Adverse event in male receiving Cytarabine
Reported by a individual with unspecified qualification from United States on 2007-10-29
Patient: male, weighing 62.9 kg (138.4 pounds)
Adverse reactions / side effects: Gastrointestinal Necrosis, Pyrexia, Constipation, Faecaloma, Gastritis, Oesophageal Candidiasis, Inappropriate Antidiuretic Hormone Secretion, Colitis, Neutropenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Cytarabine
Dosage: 70 mg
Daunorubicin HCL
Dosage: 172 mg
Methotrexate
Dosage: 30 mg
PEG-L-Asparaginase (K-H)
Dosage: 4300 iu
Prednisone TAB
Dosage: 2800 mg
Vincristine Sulfate
Dosage: 8 mg
Adverse event in 14 year old male receiving Cytarabine
Reported by a physician from United States on 2007-10-29
Patient: 14 year old male, weighing 92.0 kg (202.4 pounds)
Adverse reactions / side effects: Neutropenic Infection, Hypotension, Pancreatitis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Clofarabine. Mfr: Genzyme
Dosage: 40 mg/m2
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-01
End date: 2007-10-06
Cytarabine
Dosage: 1000 mg/m2
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-01
End date: 2007-10-05
Adverse event in male receiving Cytarabine
Reported by a individual with unspecified qualification from United States on 2007-10-29
Patient: male, weighing 73.4 kg (161.5 pounds)
Adverse reactions / side effects: Pneumonia, Respiratory Failure, Condition Aggravated, Neutropenia, Staphylococcal Bacteraemia, Chronic Obstructive Pulmonary Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Cytarabine
Dosage: 1316 mg
Daunorubicin HCL
Dosage: 212 mg
Adverse event in 8 year old male receiving Cytarabine
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-29
Patient: 8 year old male, weighing 40.0 kg (88.0 pounds)
Adverse reactions / side effects: Neuropathy, Gastrointestinal Haemorrhage, Hyperbilirubinaemia, Alanine Aminotransferase Increased, Somnolence, Multi-Organ Failure, Renal Failure, Cardio-Respiratory Arrest, Basal Ganglion Degeneration, Oesophagitis, Aspartate Aminotransferase Increased, Depressed Level of Consciousness
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Busulfan
Cytarabine
Cytoxan
Enbrel
Indication: Idiopathic Pneumonia Syndrome
Start date: 2007-07-18
End date: 2007-08-11
Other drugs received by patient: Methylprednisolone; Captopril; Caspofungin Acetate; Cyclosporine; Defibrotide; Enalaprilat; Furosemide; Meropenem; Phenobarbital TAB; Piperacillin and Tazobactam; Ranitidine HCL; Ursodiol; Sirolimus; Vancomycin; Phytomenadione
Adverse event in receiving Cytarabine
Reported by a physician from Italy on 2007-10-29
Patient:
Adverse reactions / side effects: JC Virus Infection, Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: death
Suspect drug(s):
Cyclophosphamide
Dosage: 7 g/m2, unk
Indication: Diffuse Large B-Cell Lymphoma
Cytarabine
Dosage: 2 g/m2, unk
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: 50 mg/m2, unk
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: 75 mg/m2, x2
Rituxan
Dosage: 375 mg/m2, unk
Indication: Diffuse Large B-Cell Lymphoma
Adverse event in 46 year old female receiving Cytarabine
Reported by a physician from United States on 2007-10-26
Patient: 46 year old female
Adverse reactions / side effects: Mucosal Inflammation
Adverse event resulted in: hospitalization
Suspect drug(s):
Clofarabine. Mfr: Genzyme
Dosage: 22.5 mg/m2 qd x 5 iv
Indication: Acute Myeloid Leukaemia
Start date: 2007-07-24
End date: 2007-07-28
Cytarabine
Dosage: 750 mg/m2 qd x 5 iv
Indication: Acute Myeloid Leukaemia
Start date: 2007-07-23
End date: 2007-07-27
Idarubicin HCL
Dosage: 6 mg/m2 qd x 3 iv
Indication: Acute Myeloid Leukaemia
Start date: 2007-07-23
End date: 2007-07-25
Other drugs received by patient: Compazine; Darvon; Famotidine; Levaquin; Synthroid; Paxil; Periogard; Restoril; Valtrex; Voriconazole; Wellbutrin; Xanax; Xyloxylin; YAZ; Triamcinolone
Adverse event in 22 year old female receiving Cytarabine
Reported by a physician from United States on 2007-10-26
Patient: 22 year old female, weighing 104.0 kg (228.8 pounds)
Adverse reactions / side effects: Neutropenic Infection
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Clofarabine. Mfr: Genzyme
Dosage: 40 mg/m2 qd iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-09-11
End date: 2007-09-13
Cytarabine
Dosage: 1000 mg/m2 qd iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-09-11
End date: 2007-09-14
Other drugs received by patient: RED Blood Cells
Adverse event in 43 year old male receiving Cytarabine
Reported by a individual with unspecified qualification from United Kingdom on 2007-10-26
Patient: 43 year old male
Adverse reactions / side effects: Osteonecrosis, Spinal Fracture, Osteoporosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Dosage: text:6df
Indication: Burkitt's Lymphoma
Start date: 1998-01-01
End date: 1998-09-01
Cytarabine
Indication: Burkitt's Lymphoma
Doxorubicin Hydrochloride
Dosage: text:6df
Indication: Burkitt's Lymphoma
Start date: 1998-04-01
End date: 1998-09-01
Hydrocortisone Acetate
Administration route: Oral
Indication: Burkitt's Lymphoma
Start date: 1998-04-01
End date: 1998-09-01
Methotrexate
Indication: Burkitt's Lymphoma
Start date: 1998-01-01
End date: 1998-09-01
Prednisolone
Administration route: Oral
Indication: Burkitt's Lymphoma
Start date: 1998-04-01
End date: 1998-09-01
Ritonavir
Dosage: daily dose:800mg
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Saquinavir
Dosage: daily dose:800mg
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1998-04-01
Sulfamethoxazole
Trimethoprim
Administration route: Oral
Indication: Pneumocystis Jiroveci Infection
Vincristine
Dosage: text:6df-freq:1 cyclical
Indication: Burkitt's Lymphoma
Start date: 1998-04-01
End date: 1998-09-01
Other drugs received by patient: CO-Trimoxazole
Adverse event in 63 year old male receiving Cytarabine
Reported by a physician from United States on 2007-10-26
Patient: 63 year old male
Adverse reactions / side effects: Blood Bilirubin Increased, Pneumonia, Respiratory Failure, Traumatic Intracranial Haemorrhage, Sepsis, Periorbital Haematoma, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Clofarabine. Mfr: Genzyme
Dosage: 47 mg qd x 5 iv
Indication: Acute Myeloid Leukaemia
Start date: 2007-06-28
End date: 2007-07-02
Cytarabine
Dosage: 1550 mg qd x 5 iv
Indication: Acute Myeloid Leukaemia
Start date: 2007-06-28
End date: 2007-07-02
Idarubicin HCL
Dosage: 12 mg qd x 3 iv
Indication: Acute Myeloid Leukaemia
Start date: 2007-06-01
Other drugs received by patient: Pred Forte; Xopenex; Atrovent; Solu-Medrol; Zosyn; Tigecycline; Voriconazole; Acyclovir; Flagyl; Allopurinol
Adverse event in 50 year old male receiving Cytarabine
Reported by a physician from United States on 2007-10-26
Patient: 50 year old male
Adverse reactions / side effects: Subcutaneous Abscess
Adverse event resulted in: hospitalization
Suspect drug(s):
Clofarabine. Mfr: Genzyme
Dosage: 22.5 mg/m2 qd x 5 iv
Indication: Acute Myeloid Leukaemia
Start date: 2007-08-11
End date: 2007-08-15
Cytarabine
Dosage: 750 mg/m2 qd x 5 iv
Indication: Acute Myeloid Leukaemia
Start date: 2007-08-10
End date: 2007-08-14
Idarubicin HCL
Dosage: 6 mg/m2 qd x 3 iv
Indication: Acute Myeloid Leukaemia
Start date: 2007-08-10
End date: 2007-08-12
Other drugs received by patient: Pantoprazole Sodium; Janumet; Metoprolol; Insulin Isophane; Enalapril; Clotrimazole; Tylenol (Caplet); Fentanyl; Fluconazole; Hydralazine; Daptomycin; Senokot; Insulin; Meropenem; Valacyclovir; Zofran; Lorazepam; Vitamin CAP; Gabapentin; Pregabalin; Benadryl; Propoxyphene Hydrochloride; Temazepam; Phenergan HCL
Adverse event in male receiving Cytarabine
Reported by a physician from Ireland on 2007-10-26
Patient: male
Adverse reactions / side effects: Renal Tubular Acidosis
Adverse event resulted in: life threatening event
Suspect drug(s):
Ambisome
Dosage: 300 mg, unk
Indication: Drug USE FOR Unknown Indication
Start date: 2006-12-25
End date: 2007-01-02
Cisplatin
Dosage: unk, q3w
Indication: Diffuse Large B-Cell Lymphoma
Cytarabine
Dosage: 430 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-09-25
Dexamethasone 0.5mg TAB
Dosage: unk, q3w
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-09-25
Rituximab
Dosage: 375 mg/m2, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2006-09-25
Trimethoprim
Dosage: 900 mg, 2/week
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
End date: 2007-03-01
Other drugs received by patient: Carmustine; Etoposide; Melphalan; Neupogen; Zofran; Allopurinol; Septrin; Valtrex; Zoton; Diflucan; Perindopril Erbumine; Istin; Paracetamol; Tazocin; Frusemide; Cyclizine; Gentamicin; Meropenem; Amikacin
Adverse event in 53 year old female receiving Cytarabine
Reported by a physician from United States on 2007-10-26
Patient: 53 year old female, weighing 76.8 kg (169.0 pounds)
Adverse reactions / side effects: Dyspnoea
Adverse event resulted in: life threatening event
Suspect drug(s):
Clofarabine. Mfr: Genzyme
Dosage: 40 mg/m2 qd x 5 iv
Indication: Acute Myeloid Leukaemia
Start date: 2007-05-25
End date: 2007-05-29
Cytarabine
Dosage: 40 mg/m2 qd x 5 iv
Indication: Acute Myeloid Leukaemia
Start date: 2007-05-25
End date: 2007-05-29
Other drugs received by patient: Zofran; Compazine; Cefepime; Vancomycin; Metoprolol; Protonix; Ativan; Micafungin; Potassium Chloride; Lorazepam; Sodium Bicarbonate; Vytorin; Furosemide; Etomidate; Propofol
Adverse event in 72 year old female receiving Cytarabine
Reported by a physician from United States on 2007-10-26
Patient: 72 year old female
Adverse reactions / side effects: Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Clofarabine. Mfr: Genzyme
Indication: Acute Myeloid Leukaemia
End date: 2007-07-07
Cytarabine
Dosage: 100 mg iv
Indication: Acute Myeloid Leukaemia
Start date: 2007-08-08
End date: 2007-08-13
Other drugs received by patient: Darvocet; Levaquin; Magnesium; Micro-K; Protonix; Valtrex
Adverse event in 19 year old male receiving Cytarabine
Reported by a physician from United States on 2007-10-26
Patient: 19 year old male, weighing 74.6 kg (164.1 pounds)
Adverse reactions / side effects: Hypokalaemia, Infection
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Ambisome
Indication: Drug USE FOR Unknown Indication
Clolar
Dosage: 40 mg/m2 qd x 5 iv
Indication: Acute Myeloid Leukaemia Recurrent
Start date: 2007-06-28
End date: 2007-07-02
Cytarabine
Indication: Acute Myeloid Leukaemia Recurrent
Start date: 2007-06-25
End date: 2007-06-25
Cytarabine
Dosage: 1000 mg/m2 qod iv
Indication: Acute Myeloid Leukaemia Recurrent
Start date: 2007-06-27
End date: 2007-07-02
Other drugs received by patient: Acetaminophen; Acyclovir; Cephalexin; Dexamethasone TAB; Diphenhydramine HCL; Dronabinol; Fluconazole; Heparin; Hydroxypropyl; Hydroxyzine; Lansoprazole; Lorazepam; Magnesium; Meperidine; Metoclopramide; Morphine; Multi-Vitamin; Ocular Lubricant; Ondansetron; Oxycodone HCL; Sulfamethoxazole and Trimethoprim; Trazodone HCL
Adverse event in male receiving Cytarabine
Reported by a individual with unspecified qualification from United States on 2007-10-25
Patient: male, weighing 59.2 kg (130.2 pounds)
Adverse reactions / side effects: Multi-Organ Failure
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Cytarabine
Dosage: 825 mg
End date: 2007-09-30
Daunorubicin HCL
Dosage: 298 mg
End date: 2007-09-27
Etoposide
Dosage: 330 mg
End date: 2007-09-27
Adverse event in receiving Cytarabine
Reported by a physician from Italy on 2007-10-25
Patient:
Adverse reactions / side effects: Myelodysplastic Syndrome
Adverse event resulted in: death
Suspect drug(s):
Cisplatin
Dosage: 100 mg/m2, unk
Indication: B-Cell Lymphoma
Cyclophosphamide
Dosage: 7 g/m2, unk
Indication: B-Cell Lymphoma
Cytarabine
Dosage: 2 g/m2, unk
Indication: B-Cell Lymphoma
Doxorubicin HCL
Dosage: 50 mg/m2, unk
Indication: B-Cell Lymphoma
Etoposide
Dosage: 2.4 g/m2, unk
Indication: B-Cell Lymphoma
Melphalan
Dosage: 180 mg/m2, unk
Indication: B-Cell Lymphoma
Mitomycin
Dosage: 60 mg/m2, unk
Indication: B-Cell Lymphoma
Prednisone
Indication: B-Cell Lymphoma
Rituxan
Dosage: 375 mg/m2, unk
Indication: B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Other drugs received by patient: Gcsf OR Gmcsf
Adverse event in receiving Cytarabine
Reported by a physician from Italy on 2007-10-25
Patient:
Adverse reactions / side effects: Pneumonia
Adverse event resulted in: death
Suspect drug(s):
Cisplatin
Dosage: 100 mg/m2, unk
Indication: B-Cell Lymphoma
Cyclophosphamide
Dosage: 7 g/m2, unk
Indication: B-Cell Lymphoma
Cytarabine
Dosage: 2 g/m2, unk
Indication: B-Cell Lymphoma
Doxorubicin HCL
Dosage: 50 mg/m2, unk
Indication: B-Cell Lymphoma
Doxorubicin HCL
Dosage: 75 mg/m2, unk
Etoposide
Dosage: 2.4 g/m2, unk
Indication: B-Cell Lymphoma
Melphalan
Dosage: 180 mg/m2, unk
Indication: B-Cell Lymphoma
Mitomycin
Dosage: 60 mg/m2, unk
Indication: B-Cell Lymphoma
Prednisone
Indication: B-Cell Lymphoma
Rituxan
Dosage: 375 mg/m2, unk
Indication: B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Other drugs received by patient: Gcsf OR Gmcsf
Adverse event in female receiving Cytarabine
Reported by a individual with unspecified qualification from United States on 2007-10-24
Patient: female, weighing 51.9 kg (114.2 pounds)
Adverse reactions / side effects: Cardio-Respiratory Arrest, Depressed Level of Consciousness
Suspect drug(s):
Cytarabine
Dosage: 70 mg
Daunorubicin HCL
Dosage: 113 mg
Leucovorin Calcium
Dosage: 15 mg
Methotrexate
Dosage: 15 mg
PEG-L Asparaginase (K- H)
Dosage: 3750 unit
Prednisone
Dosage: 1890 mg
Vincristine Sulfate
Dosage: 6 mg
Other drugs received by patient: Lantus; Novolog; Nystatin; Peridex; Zantac
Adverse event in receiving Cytarabine
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-24
Patient:
Adverse reactions / side effects: Unresponsive TO Stimuli, Hypotension, Pulse Absent, Apnoea
Adverse event resulted in: death
Suspect drug(s):
CEP-701
Dosage: 80 mg, bid
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2007-09-07
End date: 2007-09-30
Cytarabine
Indication: Acute Myeloid Leukaemia
Start date: 2007-09-07
Morphine Sulfate
Dosage: 2 mg, single
Indication: Drug USE FOR Unknown Indication
Start date: 2007-10-01
End date: 2007-10-01
Other drugs received by patient: Lotrel / 01289101 /; Lantus; Multivitamin / 00831701 /; Aspirin
|
